Ontogeny of valproic acid disposition and metabolism: A developmental study in postnatal lambs and adult sheep

Drug Metabolism and Disposition

Volumn 28, Issue 8, 2000, Pages 912-919

  Wong, H ^a   Kumar, S ^a   Rurak, D W ^a   Kwan, E ^a   Abbott, F S ^a   Riggs, K W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; VALERIC ACID; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG OXIDATION; DRUG PROTEIN BINDING; DRUG URINE LEVEL; FEMALE; LAMB; NEWBORN; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; SHEEP;

AGE FACTORS; ANIMALS; ANTICONVULSANTS; BLOOD PROTEINS; FATTY ACIDS, MONOUNSATURATED; FEMALE; GLUCURONIC ACID; METABOLIC CLEARANCE RATE; OXIDATION-REDUCTION; SHEEP; TIME FACTORS; VALPROIC ACID;

ANIMALIA; OVIS; OVIS ARIES;

EID: 0033856078     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Age and gender-dependent VPA-glucuronidation
2. Valproic acid: A reappraisal of its pharmacological properties and clinical efficacy in epilepsy
3. Urinary excretion of valproate and some metabolites in chronically- treated patients
4. pH-dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to β-glucuronidase-resistant forms
5. Hepatic triglyceride hydrolysis and development of ketogenesis in rabbits
6. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures
7. Decreased mitochondrial oxidation of fatty acids in pregnant mice: Possible relevance to development of acute fatty liver of pregnancy
8. Disposition of valproic acid in man
9. Disposition and protein binding of valproic acid in the developing rat
10. Pharmacokinetic study of valproic acid in a neonate
11. Developmental aspects of organic acid transport
12. In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analogue 4-pentenoic acid
13. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically active metabolite of valproic acid, in rat liver microsomal preparations
14. Postnatal development of peroxisomal and mitochondrial enzymes in rat liver
15. Pharmacokinetics of indomethacin in chronically instrumented ovine fetuses following a 3 day intravenous infusion
16. Drug disposition in the maternal-fetal unit: Studies with diphenhydramine and valproic acid in pregnant sheep
17. Role of the liver and gut in systemic diphenhydramine clearance in adult nonpregnant sheep
18. Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid
19. Valproic acid: Absorption, distribution and excretion
20. Volume of distribution terms for a drug (Ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerations
21. Valproic acid and metabolites: Pharmacological and toxicological studies
22. Cytochrome P-450-catalyzed formation of Δ4-VPA, a toxic metabolite of valproic acid
23. Valproate in the treatment of epilepsies in children
24. In vivo determination of valproate binding constants during sole and multi-drug therapy
25. Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatoxicity
26. Metabolite profiles in patients on high-dose valproate monotherapy
27. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl- 2,4-pentadienoic acid, via glucuronidation: LC/MS/MS characterization of the GSH-glucuronide diconjugates
28. Comparative study of acetaminophen disposition in sheep at three developmental stages: The fetal, neonatal and adult periods
29. Determination of valproic acid and its metabolites using gas chromatography with mass-selective detection: Application to serum and urine samples from sheep
30. Dose dependent inhibition in plasma protein binding of valproic acid during continued treatment in guinea pigs
31. Dose-dependent pharmacokinetics of valproate in guinea pigs of different ages
32. Changes in pharmacokinetics of valproic acid in guinea pigs from birth to maturity